Regulation of Jak2 tyrosine kinase by protein kinase C during macrophage differentiation of IL-3-dependent myeloid progenitor cells

被引:36
|
作者
Kovanen, PE
Junttila, I
Takaluoma, K
Saharinen, P
Valmu, L
Li, WQ
Silvennoinen, O
机构
[1] Tampere Univ, Inst Med Technol, Lab Mol Immunol, FIN-33101 Tampere, Finland
[2] Tampere Univ Hosp, Dept Clin Microbiol, Tampere, Finland
[3] Haartman Inst, Dept Virol, Helsinki, Finland
[4] Univ Helsinki, Dept Biosci, Helsinki, Finland
[5] NCI, Cellular & Mol Biol Lab, Bethesda, MD 20892 USA
关键词
D O I
10.1182/blood.V95.5.1626.005k21_1626_1632
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Differentiation of macrophages from myeloid progenitor cells depends on a discrete balance between cell growth, survival, and differentiation signals. Interleukin-8 (IL-3) supports the growth and survival of myeloid progenitor cells through the activation of Jak2 tyrosine kinase, and macrophage differentiation has been shown to be regulated by protein kinase C (PKC). During terminal differentiation of macrophages, the cells lose their mitogenic response to IL-3 and undergo growth arrest, but the underlying signaling mechanisms have remained elusive. Here we show that in IL-3-dependent 32D myeloid progenitor cells, the differentiation-inducing PKC isoforms PKC-(C) 2000 by The American Society of Hematology alpha and PKC-delta specifically caused rapid inhibition of IL-3-induced tyrosine phosphorylation. The target for this inhibition was Jak2, and the activation of PKC by 12-O-tetradecanoyl-phorbol-13-acetate treatment also abrogated Ii-a-induced tyrosine phosphorylation of Jak2 in Ba/F3 cells, The mechanism of this regulation was investigated in 32D and COS7 cells, and the inhibition of Jak2 required catalytic activity of PKC-delta and involved the phosphorylation of Jak2 on serine and threonine residues by the associated PKC-delta, Furthermore, PKC-delta inhibited the in vitro catalytic activity of Jak2, indicating that Jak2 was a direct target for PKC-delta In 32D cells, the inhibition of Jak2 either by PKC-delta, tyrosine kinase inhibitor AG490, or IL-3 deprivation caused a similar growth arrest. Reversal of PKC-delta-mediated inhibition by the overexpression of Jak2 promoted apoptosis in differentiating 32D cells. These results demonstrate a PKC-mediated negative regulatory mechanism of cytokine signaling and Jak2, and they suggest that it serves to integrate growth-promoting and differentiation signals during macrophage differentiation. (C) 2000 by The American Society of Hematology.
引用
收藏
页码:1626 / 1632
页数:7
相关论文
共 50 条
  • [21] Jak2 tyrosine kinase - A mediator of both housekeeping and ligan-dependent gene expression?
    Wallace, Tiffany A.
    Sayeski, Peter P.
    CELL BIOCHEMISTRY AND BIOPHYSICS, 2006, 44 (02) : 213 - 222
  • [22] BARICITINIB Tyrosine-Protein Kinase JAK1/JAK2 Inhibitor Treatment of Rheumatoid Arthritis
    Gras, Jordi
    DRUGS OF THE FUTURE, 2013, 38 (09) : 611 - 617
  • [23] PACRITINIB Inhibitor of Tyrosine-Protein Kinase JAK2 Inhibitor of FLT-3 Treatment of Myelofibrosis
    Verstovsek, S.
    Machida, C.
    Dean, J. P.
    Myint, H.
    DRUGS OF THE FUTURE, 2013, 38 (06) : 375 - 386
  • [24] Microinjected cDNA encoding JAK2 protein-tyrosine kinase induces DNA synthesis in NIH 3T3 cells
    Smith, MR
    Duhe, RJ
    Liu, YL
    Farrar, WL
    FEBS LETTERS, 1997, 408 (03) : 327 - 330
  • [25] Granulocyte-macrophage colony-stimulating factor and IL-5 activate mitogen-activated protein kinase through Jak2 kinase and phosphatidylinositol 3-kinase in human eosinophils
    Hiraguri, M
    Miike, S
    Sano, H
    Kurasawa, K
    Saito, Y
    Iwamoto, I
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 1997, 100 (06) : S45 - S51
  • [26] SIGNAL TRANSDUCTION PHENOMENON DURING DIFFERENTIATION OF U937 CELLS IS REGULATED BY TYROSINE KINASE AND PROTEIN-KINASE-C
    AGRAWAL, DK
    ALI, N
    FASEB JOURNAL, 1991, 5 (05): : A1339 - A1339
  • [27] POTENTIAL ROLE OF PROTEIN-KINASE-C ON THE DIFFERENTIATION OF ERYTHROID PROGENITOR CELLS
    LEE, SJ
    CHO, IK
    HUH, IH
    YOM, YK
    ANN, HS
    ARCHIVES OF PHARMACAL RESEARCH, 1995, 18 (02) : 90 - 99
  • [28] INTRODUCTION OF V-ABL ONCOGENE INDUCES MONOCYTIC DIFFERENTIATION OF AN IL-3-DEPENDENT MYELOID PROGENITOR-CELL LINE
    KELLER, JR
    RUSCETTI, SK
    RUSCETTI, FW
    ONCOGENE, 1990, 5 (04) : 549 - 555
  • [29] TG-101348 Tyrosine-Protein Kinase JAK2 Inhibitor Receptor-Type Tyrosine-Protein Kinase FLT3 Inhibitor Treatment of Myeloproliferative Diseases
    Harry, Brian L.
    Eckhardt, S. Gail
    Jimeno, Antonio
    DRUGS OF THE FUTURE, 2011, 36 (11) : 819 - 824
  • [30] THE PROTEIN-TYROSINE KINASE JAK2 IS ACTIVATED IN NEUTROPHILS FROM PATIENTS WITH SEVERE CONGENITAL NEUTROPENIA
    RAUPRICH, P
    KASPER, B
    TIDOW, N
    WELTE, K
    BLOOD, 1995, 86 (12) : 4500 - 4505